Ultrasound measurements to predict bleeding risk in placenta previa
Part of Women’s health & pregnancy clinical trials.
This study uses special ultrasound measurements to estimate the chance of bleeding before delivery in people who have placenta previa but no symptoms. The goal is to help clinicians better predict risk and plan care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and have placenta previa seen on ultrasound (placenta covering the cervix opening).
- You are between 28 and 37 weeks pregnant right now.
- You are not having any bleeding or other warning signs in this pregnancy.
- You are carrying one baby (not twins or more).
- You do not have certain pregnancy or health factors, like preterm labor/ruptured water or major medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at pregnant women with a condition called placenta previa, where the placenta covers part or all of the cervix. Researchers want to create a scoring system to predict how the pregnancy and delivery might go, so they can offer better care.
This study tests whether a medicine called tranexamic acid, given during a C-section, can help reduce blood loss in women who have a placenta previa. It is for women near full term who are otherwise healthy.
This study tests whether a silicone cervical pessary can help reduce bleeding in pregnant women with placenta previa (a low-lying placenta near the cervix). You may qualify if you are between 20 and 30 weeks pregnant and have been diagnosed with this condition.
This trial compares delivering at 36 weeks versus 37 weeks for pregnant women with a condition called placenta previa with accreta, where the placenta covers the cervix and grows too deeply into the womb. The goal is to find the best time for delivery to improve safety for both mother and baby.
This trial compares two medicines, tranexamic acid and vasopressin, to see which works better at reducing bleeding during planned C-sections for women with placenta previa. It aims to find a safer way to control blood loss during delivery.
This study looks at a possible link between certain proteins in the blood (VEGF family) and a pregnancy condition called placenta previa, using genetic information from existing studies. It is not a treatment trial, but a research study that analyzes data to understand causes.
Hear when a new Placenta Previa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.